Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,697 public trials 1,039 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC

NCT01042288

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Medical Oncology Associates of Augusta Augusta, Georgia, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
View all 13 locations
View Trial Details
Completed

A Phase 1 Study in Participants With Advanced Cancer

NCT01115790

Conditions
Advanced Cancer, Anal Squamous Cell Carcinoma, Anus Diseases, +30 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City, Oklahoma, United States
  • Sarah Cannon Research Institute SCRI Nashville, Tennessee, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

NCT02728492

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Russian Oncological Research Center n.a. N. N. Blokhin RAMS Moscow, Russia
  • State Budgetary Healthcare Institution of Stavropol Territory "Pyatigorsk oncology dispensary" Pyatigorsk, Russia
  • Saint-Peterburg State Budgetary healthcare Institution "City Clinical Oncology Dispensary" Saint Petersburg, Russia
  • BioEq LLC Saint Petersburg, Russia
View Trial Details
Completed

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

NCT00257608

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sacred Heart Medical Onc Group Mobile, Alabama, United States
  • St. Edward Mercy Medical Ctr Fort Smith, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
View all 247 locations
View Trial Details
Completed

A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer

NCT01792479

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Investigative Site #10 Goodyear, Arizona, United States
  • Investigative Site #04 Los Angeles, California, United States
  • Investigative Site #02 Fort Meyers, Florida, United States
  • Investigative Site #08 Newnan, Georgia, United States
View all 17 locations
View Trial Details
Completed

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

NCT00609804

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Wellstar Cancer Research Marietta, Georgia, United States
  • Providence Medical Group Terre Haute, Indiana, United States
View all 16 locations
View Trial Details

Related conditions